These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 38012956)

  • 21. Serologic testing of a panel of five antibodies in inflammatory bowel diseases: Diagnostic value and correlation with disease phenotype.
    Wang ZZ; Shi K; Peng J
    Biomed Rep; 2017 Apr; 6(4):401-410. PubMed ID: 28413638
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PR3-ANCA: a promising biomarker for ulcerative colitis with extensive disease.
    Mahler M; Bogdanos DP; Pavlidis P; Fritzler MJ; Csernok E; Damoiseaux J; Bentow C; Shums Z; Forbes A; Norman GL
    Clin Chim Acta; 2013 Sep; 424():267-73. PubMed ID: 23806819
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Diagnostic role of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in pediatric inflammatory bowel disease].
    Kim JE; Kim KS; Seo JK
    Korean J Gastroenterol; 2003 Oct; 42(4):297-302. PubMed ID: 14634349
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Assessment of usefulness of anti-Saccharomyces cerevisiae and anti-neutrophil cytoplasmic antibodies in patients with unspecific inflammatory bowel diseases].
    Mokrowiecka A; Gasiorowska A; Małecka-Panas E
    Pol Merkur Lekarski; 2004; 17 Suppl 1():22-6. PubMed ID: 15603341
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnostic value of antineutrophil cytoplasmic antibodies and anti-Saccharomyces cerevisiae antibody in Iranian patients with inflammatory bowel disease.
    Bahari A; Aarabi M; Aarabi M; Hedayati M; Jarollahi A; Firouzi F; Aghazadeh R; Zali MR; Hashemi M
    Acta Gastroenterol Belg; 2009; 72(3):301-5. PubMed ID: 19902862
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PR3-ANCA and panel diagnostics in pediatric inflammatory bowel disease to distinguish ulcerative colitis from Crohn's disease.
    Horn MP; Peter AM; Righini Grunder F; Leichtle AB; Spalinger J; Schibli S; Sokollik C
    PLoS One; 2018; 13(12):e0208974. PubMed ID: 30557305
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serological markers of inflammatory bowel disease in children from the Western region of Saudi Arabia.
    Saadah OI; Al-Mughales JA
    Arab J Gastroenterol; 2013 Jun; 14(2):78-82. PubMed ID: 23820506
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnostic precision of anti-Saccharomyces cerevisiae antibodies and perinuclear antineutrophil cytoplasmic antibodies in inflammatory bowel disease.
    Reese GE; Constantinides VA; Simillis C; Darzi AW; Orchard TR; Fazio VW; Tekkis PP
    Am J Gastroenterol; 2006 Oct; 101(10):2410-22. PubMed ID: 16952282
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of a novel antigen for Crohn's disease.
    Wei Y; Chen T; Yang W; Li H; Fang C; Liu Q; Chen Y; Mei Q
    Scand J Gastroenterol; 2021 Dec; 56(12):1427-1433. PubMed ID: 34487462
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-Saccharomyces cerevisiae mannan antibodies and antineutrophil cytoplasmic autoantibodies in Greek patients with inflammatory bowel disease.
    Koutroubakis IE; Petinaki E; Mouzas IA; Vlachonikolis IG; Anagnostopoulou E; Castanas E; Maniatis AN; Kouroumalis EA
    Am J Gastroenterol; 2001 Feb; 96(2):449-54. PubMed ID: 11232689
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Presence of anti-proteinase 3 antineutrophil cytoplasmic antibodies (anti-PR3 ANCA) as serologic markers in inflammatory bowel disease.
    Arias-Loste MT; Bonilla G; Moraleja I; Mahler M; Mieses MA; Castro B; Rivero M; Crespo J; López-Hoyos M
    Clin Rev Allergy Immunol; 2013 Aug; 45(1):109-16. PubMed ID: 23345025
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-Saccharomyces cerevisiae antibody does not differentiate between Crohn's disease and intestinal tuberculosis.
    Makharia GK; Sachdev V; Gupta R; Lal S; Pandey RM
    Dig Dis Sci; 2007 Jan; 52(1):33-9. PubMed ID: 17160471
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of Immunohistochemistry and serology in subclassifying the Inflammatory Bowel Disease cases diagnosed as Inflammatory Bowel Diseases---unclassified on colonic biopsies.
    Paridhi ; Singh K; Kumar V; Tewari S; Misra V; Misra SP; Dwivedi M
    Indian J Pathol Microbiol; 2022; 65(3):558-564. PubMed ID: 35900482
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnostic Value of ASCA and Atypical p-ANCA in Differential Diagnosis of Inflammatory Bowel Disease.
    Mokhtarifar A; Ganji A; Sadrneshin M; Bahari A; Esmaeilzadeh A; Ghafarzadegan K; Nikpour S
    Middle East J Dig Dis; 2013 Apr; 5(2):93-7. PubMed ID: 24829676
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CLASSICAL SEROLOGICAL MARKERS IN PEDIATRIC INFLAMMATORY BOWEL DISEASE IN BRAZIL.
    Rodrigues M; Bueno C; Lomazi EA; Fernandes MIM; Neufeld CB; D'Amico MFM; Patiño FRA
    Arq Gastroenterol; 2021; 58(4):495-503. PubMed ID: 34909856
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [p-ANCA and ASCA antibodies in the differential diagnosis between ulcerative rectocolitis and Crohn's disease].
    Lecis P; Germanà B; Papa N; Bertiato G; Doglioni C; Galliani E; Biedo FC
    Recenti Prog Med; 2002 May; 93(5):308-13. PubMed ID: 12050913
    [TBL] [Abstract][Full Text] [Related]  

  • 37. pANCA and ASCA in the diagnosis of different subtypes of inflammatory bowel disease.
    Mokrowiecka A; Gasiorowska A; Malecka-Panas E
    Hepatogastroenterology; 2007; 54(77):1443-8. PubMed ID: 17708273
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel anti-glycan antibodies related to inflammatory bowel disease diagnosis and phenotype.
    Seow CH; Stempak JM; Xu W; Lan H; Griffiths AM; Greenberg GR; Steinhart AH; Dotan N; Silverberg MS
    Am J Gastroenterol; 2009 Jun; 104(6):1426-34. PubMed ID: 19491856
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serological markers predict inflammatory bowel disease years before the diagnosis.
    van Schaik FD; Oldenburg B; Hart AR; Siersema PD; Lindgren S; Grip O; Teucher B; Kaaks R; Bergmann MM; Boeing H; Carbonnel F; Jantchou P; Boutron-Ruault MC; Tjønneland A; Olsen A; Crowe FL; Peeters PH; van Oijen MG; Bueno-de-Mesquita HB
    Gut; 2013 May; 62(5):683-8. PubMed ID: 22842615
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Higher titers of anti-Saccharomyces cerevisiae antibodies IgA and IgG are associated with more aggressive phenotypes in Romanian patients with Crohn's disease.
    Gologan S; Iacob R; Preda C; Vadan R; Cotruta B; Catuneanu AM; Iacob S; Constantinescu I; Gheorghe L; Iobagiu S; Gheorghe C; Diculescu M
    J Gastrointestin Liver Dis; 2012 Mar; 21(1):39-44. PubMed ID: 22457858
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.